Bringing Neglected Tropical Diseases out of the Silo 30/01/2023 Simon Bland The number of people requiring treatment for Neglected Tropical Diseases (NTDs) decreased from 2.19 to 1.65 billion between 2010 and 2021 – an impressive 25 percent decline. However, interlinked challenges, including the COVID pandemic and, now, accelerating patterns of climate change are putting this progress at risk. On World NTD Day, we need to recognise […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Conflict, Displacement and Living with a Chronic Disease 12/12/2022 Éimhín Ansbro, Grace Dubois, Nicolai Haugaard, Peter Klansø & Micaela Serafini On the occasion of Universal Health Coverage Day, thought leaders on the front lines outline the challenges and opportunities of health systems in conflicts. The last decade of 12-year-old Zaynab’s life has been spent in an informal settlement in Lebanon, after her family fled from the Syrian conflict. She shares a three-room tent with her […] Continue reading -> Time to Bring the Full Picture on Women’s Health into Focus 09/12/2022 Jane Madden, Emma Feeny & Monika Arora As we observe Universal Health Coverage day, it’s time to look again at gender barriers to health care, and particularly health care for chronic diseases. Monowara lives in the Khulna Division of Bangladesh. A mother of four, she is from a rural community experiencing significant levels of poverty. Now in her sixties, she spent 13 […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Health Systems and Cancer Services Need to Better Care for Older Adults 17/10/2022 Sonali Johnson A lack of expertise in geriatric oncology means that cancer in older adults is often confused with other signs of ageing and diagnosed too late. Dr Sonali Johnson sets out a blueprint for addressing this barrier – one of the many topics to be discussed at the World Cancer Congress, hosted by the Union for […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Conflict, Displacement and Living with a Chronic Disease 12/12/2022 Éimhín Ansbro, Grace Dubois, Nicolai Haugaard, Peter Klansø & Micaela Serafini On the occasion of Universal Health Coverage Day, thought leaders on the front lines outline the challenges and opportunities of health systems in conflicts. The last decade of 12-year-old Zaynab’s life has been spent in an informal settlement in Lebanon, after her family fled from the Syrian conflict. She shares a three-room tent with her […] Continue reading -> Time to Bring the Full Picture on Women’s Health into Focus 09/12/2022 Jane Madden, Emma Feeny & Monika Arora As we observe Universal Health Coverage day, it’s time to look again at gender barriers to health care, and particularly health care for chronic diseases. Monowara lives in the Khulna Division of Bangladesh. A mother of four, she is from a rural community experiencing significant levels of poverty. Now in her sixties, she spent 13 […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Health Systems and Cancer Services Need to Better Care for Older Adults 17/10/2022 Sonali Johnson A lack of expertise in geriatric oncology means that cancer in older adults is often confused with other signs of ageing and diagnosed too late. Dr Sonali Johnson sets out a blueprint for addressing this barrier – one of the many topics to be discussed at the World Cancer Congress, hosted by the Union for […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Conflict, Displacement and Living with a Chronic Disease 12/12/2022 Éimhín Ansbro, Grace Dubois, Nicolai Haugaard, Peter Klansø & Micaela Serafini On the occasion of Universal Health Coverage Day, thought leaders on the front lines outline the challenges and opportunities of health systems in conflicts. The last decade of 12-year-old Zaynab’s life has been spent in an informal settlement in Lebanon, after her family fled from the Syrian conflict. She shares a three-room tent with her […] Continue reading -> Time to Bring the Full Picture on Women’s Health into Focus 09/12/2022 Jane Madden, Emma Feeny & Monika Arora As we observe Universal Health Coverage day, it’s time to look again at gender barriers to health care, and particularly health care for chronic diseases. Monowara lives in the Khulna Division of Bangladesh. A mother of four, she is from a rural community experiencing significant levels of poverty. Now in her sixties, she spent 13 […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Health Systems and Cancer Services Need to Better Care for Older Adults 17/10/2022 Sonali Johnson A lack of expertise in geriatric oncology means that cancer in older adults is often confused with other signs of ageing and diagnosed too late. Dr Sonali Johnson sets out a blueprint for addressing this barrier – one of the many topics to be discussed at the World Cancer Congress, hosted by the Union for […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Time to Bring the Full Picture on Women’s Health into Focus 09/12/2022 Jane Madden, Emma Feeny & Monika Arora As we observe Universal Health Coverage day, it’s time to look again at gender barriers to health care, and particularly health care for chronic diseases. Monowara lives in the Khulna Division of Bangladesh. A mother of four, she is from a rural community experiencing significant levels of poverty. Now in her sixties, she spent 13 […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Health Systems and Cancer Services Need to Better Care for Older Adults 17/10/2022 Sonali Johnson A lack of expertise in geriatric oncology means that cancer in older adults is often confused with other signs of ageing and diagnosed too late. Dr Sonali Johnson sets out a blueprint for addressing this barrier – one of the many topics to be discussed at the World Cancer Congress, hosted by the Union for […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Health Systems and Cancer Services Need to Better Care for Older Adults 17/10/2022 Sonali Johnson A lack of expertise in geriatric oncology means that cancer in older adults is often confused with other signs of ageing and diagnosed too late. Dr Sonali Johnson sets out a blueprint for addressing this barrier – one of the many topics to be discussed at the World Cancer Congress, hosted by the Union for […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Health Systems and Cancer Services Need to Better Care for Older Adults 17/10/2022 Sonali Johnson A lack of expertise in geriatric oncology means that cancer in older adults is often confused with other signs of ageing and diagnosed too late. Dr Sonali Johnson sets out a blueprint for addressing this barrier – one of the many topics to be discussed at the World Cancer Congress, hosted by the Union for […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As NCDs Increase in Poorer Countries, Innovative Partnerships Have Become Essential 27/09/2022 Alison Cox, Megha Kumar & Anne Stake Infectious diseases like HIV, tuberculosis and malaria have long been the biggest public health challenges in low- and middle-income countries (LMICs) but over the past decade, non-communicable diseases (NCDs) have risen at an alarming rate. While every country faces a growing NCD burden, low- and middle-income countries are seeing the fastest increase. This epidemiological shift […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Political Leaders Need to invest in Global Research & Development to Prepare for Next Pandemic 30/08/2022 CEPI & UNITE Recently, the Coalition for Epidemic Preparedness (CEPI) launched a $3.5 billion plan of investment in ground-breaking R&D, linked to equitable access commitments, which aims to transform the world’s ability to respond to new epidemic and pandemic threats and catalyze cooperation across a coalition of public and private sector partners. As parliamentarians from across the European […] Continue reading -> Posts navigation Older posts